References
- Bales JR, Bell JD, Nicholson JK, et al. (1988). Metabolic profiling of body fluids by proton NMR: Self-poisoning episodes with paracetamol (acetaminophen). Magn Reson Med 6:300–306
- Bales JR, Higham DP, Howe I, et al. (1984a). Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30:426–432
- Bales JR, Nicholson JK, Sadler PJ. (1985). Two-dimensional proton nuclear magnetic resonance “maps” of acetaminophen metabolites in human urine. Clin Chem 31:757–762
- Bales JR, Sadler PJ, Nicholson JK, Timbrell JA. (1984b). Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clin Chem 30:1631–1636
- Beckonert O, Coen M, Keun HC, et al. (2010). High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5:1019–1032
- Beckonert O, Keun HC, Ebbels TM, et al. (2007). Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692–2703
- Benton HP, Want E, Keun HC, et al. (2012). Intra- and interlaboratory reproducibility of ultra performance liquid chromatography-time-of-flight mass spectrometry for urinary metabolic profiling. Anal Chem 84:2424–2432
- Bernal W, Auzinger G, Dhawan A, Wendon J. (2010). Acute liver failure. Lancet 376:190–201
- Bernal W, Hyyrylainen A, Gera A, et al. (2013). Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 59:74–80
- Bhattacharyya S, Pence L, Beger R, et al. (2013). Acylcarnitine profiles in acetaminophen toxicity in the mouse: Comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites 3:606–622
- Bi H, Li F, Krausz KW, et al. (2013). Targeted metabolomics of serum acylcarnitines evaluates hepatoprotective effect of Wuzhi tablet (Schisandra sphenanthera extract) against acute acetaminophen toxicity. Evid Based Complement Alternat Med 2013:985257
- Calpena E, Casado M, Martinez-Rubio D, et al. (2013). 5-Oxoprolinuria in heterozygous patients for 5-oxoprolinase (OPLAH) missense changes. JIMD Rep 7:123–128
- Chan EC, Pasikanti KK, Nicholson JK. (2011). Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc 6:1483–1499
- Chen C, Krausz KW, Idle JR, Gonzalez FJ. (2008). Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem 283:4543–4559
- Chen C, Krausz KW, Shah YM, et al. (2009). Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol 22:699–707
- Chen W, Shockcor JP, Tonge R, et al. (1999). Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct. Biochemistry 38:8159–8166
- Clayton TA, Baker D, Lindon JC, et al. (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 106:14728–14733
- Clayton TA, Lindon JC, Cloarec O, et al. (2006). Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073–1077
- Cloarec O, Dumas ME, Craig A, et al. (2005). Statistical total correlation spectroscopy: An exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem 77:1282–1289
- Coen M. (2010). A metabonomic approach for mechanistic exploration of pre-clinical toxicology. Toxicology 278:326–340
- Coen M, Hong YS, Cloarec O, et al. (2007). Heteronuclear 1H–31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: Application to galactosamine-induced hepatotoxicity. Anal Chem 79:8956–8966
- Coen M, Lenz EM, Nicholson JK, et al. (2003). An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 16:295–303
- Coen M, Ruepp SU, Lindon JC, et al. (2004). Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J Pharm Biomed Anal 35:93–105
- Dahl N, Pigg M, Ristoff E, et al. (1997). Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet 6:1147–1152
- Dahlin DC, Miwa GT, Lu AY, Nelson SD. (1984). N-acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327–1331
- Dai W, Huang Q, Yin P, et al. (2012). Comprehensive and highly sensitive urinary steroid hormone profiling method based on stable isotope-labeling liquid chromatography-mass spectrometry. Anal Chem 84:10245–10251
- Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. (2000). Pyroglutamic acidemia: A cause of high anion gap metabolic acidosis. Crit Care Med 28:1803–1807
- Dona AC, Jimenez B, Schäfer H, et al. (2014). Precision high throughput proton NMR spectroscopy of human urine, serum and plasma for large-scale metabolic phenotyping. Anal Chem 86:9887–9894
- Dunn WB, Broadhurst D, Begley P, et al. (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6:1060–1083
- Ebbels TM, Keun HC, Beckonert OP, et al. (2007). Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: The consortium on metabonomic toxicology screening approach. J Proteome Res 6:4407–4422
- Everett JR, Loo RL, Pullen FS. (2013). Pharmacometabonomics and personalized medicine. Ann Clin Biochem 50:523–545
- Geenen S, Du Preez FB, Reed M, et al. (2012). A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolism. Eur J Pharm Sci 46:233–243
- Geenen S, Guallar-Hoyas C, Michopoulos F, et al. (2011a). HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. J Pharm Biomed Anal 56:655–663
- Geenen S, Michopoulos F, Kenna JG, et al. (2011b). HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium. J Pharm Biomed Anal 54:1128–1135
- Ghauri FY, Mclean AE, Beales D, et al. (1993). Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol). Biochem Pharmacol 46:953–957
- Godejohann M, Tseng LH, Braumann U, et al. (2004). Characterization of a paracetamol metabolite using on-line LC-SPE-NMR-MS and a cryogenic NMR probe. J Chromatogr A 1058:191–196
- Holmes E, Kinross J, Gibson GR, et al. (2012). Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 4:137
- Holmes E, Loo RL, Cloarec O, et al. (2007). Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Anal Chem 79:2629–2640
- Jaeschke H, Williams CD, McGill MR. (2012). Caveats of using acetaminophen hepatotoxicity models for natural product testing. Toxicol Lett 215:40–41
- Jaeschke H, Williams CD, McGill MR, Farhood A. (2010). Herbal extracts as hepatoprotectants against acetaminophen hepatotoxicity. World J Gastroenterol 16:2448–2450
- Jaeschke H, Williams CD, McGill MR, et al. (2013). Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. Food Chem Toxicol 55:279–289
- Jimenez B, Mirnezami R, Kinross J, et al. (2013). 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. J Proteome Res 12:959–968
- Johnson CH, Athersuch TJ, Wilson ID, et al. (2008). Kinetic and J-resolved statistical total correlation NMR spectroscopy approaches to structural information recovery in complex reacting mixtures: Application to acyl glucuronide intramolecular transacylation reactions. Anal Chem 80:4886–4895
- Jollow DJ, Mitchell JR, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 187:195–202
- Keun HC, Athersuch TJ, Beckonert O, et al. (2008). Heteronuclear 19F–1H statistical total correlation spectroscopy as a tool in drug metabolism: Study of flucloxacillin biotransformation. Anal Chem 80:1073–1079
- Keun HC, Ebbels TM, Antti H, et al. (2002). Analytical reproducibility in 1H NMR-based metabonomic urinalysis. Chem Res Toxicol 15:1380–1386
- Lau SS, Monks TJ, Gillette JR. (1984). Multiple reactive metabolites derived from bromobenzene. Drug Metab Dispos 12:291–296
- Lee WM. (2012). Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol 26:3–16
- Li F, Lu J, Ma X. (2011). Profiling the reactive metabolites of xenobiotics using metabolomic technologies. Chem Res Toxicol 24:744–751
- Li H, Jia W. (2013). Cometabolism of microbes and host: Implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther 94:574–581
- Lindon JC, Keun HC, Ebbels TM, et al. (2005). The Consortium for Metabonomic Toxicology (COMET): Aims, activities and achievements. Pharmacogenomics 6:691–699
- Lindon JC, Nicholson JK, Holmes E, et al. (2003). Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187:137–146
- Madsen R, Lundstedt T, Trygg J. (2010). Chemometrics in metabolomics – a review in human disease diagnosis. Anal Chim Acta 659:23–33
- McGill MR, Sharpe MR, Williams CD, et al. (2012a). The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 122:1574–1583
- McGill MR, Williams CD, Xie Y, et al. (2012b). Acetaminophen-induced liver injury in rats and mice: Comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 264:387–394
- McGill MR, Li F, Sharpe MR, et al. (2014a). Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol 88:391–401
- McGill MR, Staggs VS, Sharpe MR, et al. (2014b). Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 60:1336–1345
- Mirnezami R, Jimenez B, Li JV, et al. (2014). Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann Surg 259:1138–1149
- Nelson SD. (1982). Metabolic activation and drug toxicity. J Med Chem 25:753–765
- Nicholls AW, Caddick S, Wilson ID, et al. (1995). High resolution NMR spectroscopic studies on the metabolism and futile deacetylation of 4-hydroxyacetanilide (paracetamol) in the rat. Biochem Pharmacol 49:1155–1164
- Nicholls AW, Farrant RD, Shockcor JP, et al. (1997). NMR and HPLC-NMR spectroscopic studies of futile deacetylation in paracetamol metabolites in rat and man. J Pharm Biomed Anal 15:901–910
- Nicholson JK, Connelly J, Lindon JC, Holmes E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161
- Nicholson JK, Holmes E, Kinross J, et al. (2012). Host-gut microbiota metabolic interactions. Science 336:1262–1267
- Nicholson JK, Lindon JC, Holmes E. (1999). ‘Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189
- O'Brien LM, Hooper M, Flemmer M, Marik PE. (2012). Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: An under diagnosed phenomenon. BMJ Case Rep 2012:pii: bcrbcr0320126020
- Ramautar R, Nevedomskaya E, Mayboroda OA, et al. (2011). Metabolic profiling of human urine by CE-MS using a positively charged capillary coating and comparison with UPLC-MS. Mol Biosyst 7:194–199
- Ramautar R, Somsen GW, De Jong GJ. (2014). CE-MS for metabolomics: Developments and applications in the period 2012–2014. Electrophoresis. doi: 10.1002/elps.201400388. [Epub ahead of print]
- Robinette SL, Lindon JC, Nicholson JK. (2013). Statistical spectroscopic tools for biomarker discovery and systems medicine. Anal Chem 85:5297–5303
- Saito C, Zwingmann C, Jaeschke H. (2010). Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 51:246–254
- Sands CJ, Coen M, Ebbels TM, et al. (2011). Data-driven approach for metabolite relationship recovery in biological 1H NMR data sets using iterative statistical total correlation spectroscopy. Anal Chem 83:2075–2082
- Shi ZZ, Habib GM, Rhead WJ, et al. (1996). Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet 14:361–365
- Shipkova P, Vassallo JD, Aranibar N, et al. (2011). Urinary metabolites of 2-bromoethanamine identified by stable isotope labelling: Evidence for carbamoylation and glutathione conjugation. Xenobiotica 41:144–154
- Shockcor JP, Unger SE, Wilson ID, et al. (1996). Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. Anal Chem 68:4431–4435
- Soga T, Baran R, Suematsu M, et al. (2006). Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281:16768–16776
- Spraul M, Freund AS, Nast RE, et al. (2003). Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: Application to the analysis of acetaminophen metabolites in urine. Anal Chem 75:1536–1541
- Spraul M, Hofmann M, Lindon JC, et al. (1994). Evaluation of liquid chromatography coupled with high-field 1H NMR spectroscopy for drug metabolite detection and characterization: The identification of paracetamol metabolites in urine and bile. NMR Biomed 7:295–303
- Sun J, Schnackenberg LK, Beger RD. (2009). Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics. Drug Metab Lett 3:130–136
- Sun J, Schnackenberg LK, Holland RD, et al. (2008). Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. J Chromatogr B Analyt Technol Biomed Life Sci 871:328–340
- Trygg J, Holmes E, Lundstedt T. (2007). Chemometrics in metabonomics. J Proteome Res 6:469–479
- Want EJ, Coen M, Masson P, et al. (2010a). Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: Application to experimental toxicology studies. Anal Chem 82:5282–5289
- Want EJ, Masson P, Michopoulos F, et al. (2013). Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 8:17–32
- Want EJ, Wilson ID, Gika H, et al. (2010b). Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5:1005–1018
- Waters NJ, Waterfield CJ, Farrant RD, et al. (2006). Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: Novel induction of 5-oxoprolinosis. J Proteome Res 5:1448–1459
- Wilson ID, Nicholson JK. (1988). Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine. J Pharm Biomed Anal 6:151–165
- Winnike JH, Li Z, Wright FA, et al. (2010). Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther 88:45–51
- Woolbright BL, McGill MR, Staggs VS, et al. (2014). Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci 142:436–444
- Yamazaki M, Miyake M, Sato H, et al. (2013). Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicol Appl Pharmacol 268:79–89